Published on 7 May 2024 on Zacks via Yahoo Finance
Soft Instrument Orders Likely to Hurt PacBio's (PACB) Q1 Earnings
Pacific Biosciences of California, Inc. PACB, popularly known as PacBio, is scheduled to release first-quarter 2024 results on May 9.
In the last reported quarter, the company’s adjusted loss per share of 27 cents was narrower than the Zacks Consensus Estimate of a loss of 31 cents per share. Over the trailing four quarters, its earnings outperformed the Zacks Consensus Estimate on all occasions, delivering an earnings surprise of 13.1%, on average.